BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21835258)

  • 1. The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function.
    Yan YX; Li WZ; Huang YQ; Liao WX
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):29-35. PubMed ID: 21835258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
    Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
    Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperin Enhances the Sensitivity of HCT8/VCR Colon Cancer Cell Line to Vincristine by Down-Regulating P-Glycoprotein.
    Wang LM; Zhang MY; Zhu QS; Lu CF; Bai X
    Clin Lab; 2018 Mar; 64(3):269-275. PubMed ID: 29739100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Celecoxib enhances chemosensitivity of oral cancer cells by blocking cell cycle progression in vitro].
    Liao W; Yan Y; Huang Y; Li W
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):885-8. PubMed ID: 23803204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Celecoxib enhances the chemotherapy sensitivity of KB/VCR cell lines to vincristine].
    Yan Y; Li W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Aug; 31(4):403-7. PubMed ID: 23991582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ; Bi H; Feng JQ; Cao JG
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line.
    Roy KR; Reddy GV; Maitreyi L; Agarwal S; Achari C; Vali S; Reddanna P
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):903-11. PubMed ID: 19685055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin inhibits proliferation and drug resistance in KB/VCR oral cancer cells and enhances its sensitivity to vincristine.
    Yuan Z; Wang H; Hu Z; Huang Y; Yao F; Sun S; Wu B
    Nutr Cancer; 2015; 67(1):126-36. PubMed ID: 25514492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
    Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
    Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of celecoxib on enhancing the chemotherapic sensitivity of hydroxyurea to K562 cells and its mechanism].
    Liu DS; Zhang GS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):495-9. PubMed ID: 16137030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
    Kim SH; Kim SH; Song YC; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression.
    Li WZ; Huo QJ; Wang XY; Xu F
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):113-9. PubMed ID: 20709621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
    Xi GM; Sun B; Jiang HH; Kong F; Yuan HQ; Lou HX
    Bioorg Med Chem; 2010 Sep; 18(18):6725-33. PubMed ID: 20724170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Celecoxib increased cellular ATRA sensitivity of human colon cancer cell lines through COX-2-independent mechanisms].
    Liu JP; Wei HB; Zheng ZH; Guo WP; Fang JF
    Yao Xue Xue Bao; 2009 Dec; 44(12):1353-8. PubMed ID: 21351468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.